Liminatus Pharma Inc. Class A-28LIMNWPreferred / convertible

13F holders, Q4 2025 (December 31)
24holders −2
2new positions
3sold out
2famous investors
$0.04avg. 13F price*

At the end of Q4 2025, 24 institutions reported holding Liminatus Pharma Inc. Class A-28 (LIMNW) in their 13F filings, down 2 from Q3 2025. 2 opened new positions and 3 sold out. The largest holders were Clear Street Group Inc. ($28K), Aristeia Capital, L.L.C. ($12K) and Linden Advisors LP ($11K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Steve Cohen ( of Point72 Asset Management's portfolio).

Company
Liminatus Pharma Inc. Class A-28
CUSIP
53271X116
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q2 2025: 25Q2 2025Q3 2025: 26Q3 2025Q4 2025: 24Q4 2025Q1 2026: 21Q1 2026Q2 2026: 22Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions2$1K
Exits3$25K

All 13F filers, Q3 2025 → Q4 2025: 40,228 shares bought and 202,244 shares sold, net −162,016 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 24 holders
Clear Street Group Inc. — Reduce -0.0% 805,177 $28K
Aristeia Capital, L.L.C. — No change 319,510 $12K
Linden Advisors LP — No change 268,199 $11K
Saba Capital Management, L.P. — No change 233,761 $9K
Polar Asset Management Partners Inc. — No change 122,688 $5K
Moore Capital Management, LP — No change 125,000 $4K
MMCAP International Inc. SPC — No change 111,745 $4K
D. E. Shaw & Co. — No change 83,353 $3K
Wolverine Asset Management LLC — Reduce -0.1% 62,795 $2K
Blue Owl Capital Holdings LP — No change 50,000 $2K
Periscope Capital Inc. — No change 47,500 $2K
Toronto Dominion Bank — No change 35,100 $1K
LMR Partners LLP — No change 29,961 $1K
GTS Securities LLC — Reduce -1.0% 29,700 $1K
Arena Capital Advisors, LLC- CA — No change 29,166 $1K
Jane Street Group, LLC — Reduce -0.6% 24,274 $850
Susquehanna International Group, LLP — New 23,906 $837
Limestone Investment Advisors LP — No change 22,562 $790
Point72 Asset Management — New 12,400 $434
Dupont Capital Management Corp. — No change 6,250 $219
UBS Group AG — Add +1352.4% 4,212 $147
HGC Investment Management Inc. — No change 1,250 $44
Bank of America Corp. — Reduce -50.0% 100 $4
Flow Traders U.S. LLC — No change 13,110 $0

"% of holder's portfolio" is LIMNW's weight in each manager's 13F, not the share of Liminatus Pharma Inc. Class A-28 the manager owns.